期刊文献+

Ly49A转基因淋巴细胞对异基因骨髓移植后GVHD和GVL的影响 被引量:1

Effect of Ly49A transfected lymphocytes on graft versus host disease and graft versus leukemia effect after allogeneic bone marrow transplantation
原文传递
导出
摘要 目的 观察Ly49A基因转染淋巴细胞对异基因骨髓移植后移植物抗宿主病 (GVHD)和移植物抗白血病效应 (GVL)的影响。方法 经逆转录病毒介导将Ly49A基因转染至C57BL/ 6小鼠的淋巴细胞 ,以C57BL/ 6(H 2 b)小鼠为供者 ,以接种EL961 1红白血病细胞的BALB/c(H 2 d)小鼠为受者 ,进行脾淋巴细胞和骨髓细胞联合移植 ,建立异基因急性GVHD模型 ,观察Ly49A基因转染的淋巴细胞对GVHD和GVL的影响。结果 在未进行移植的单纯照射组 ,小鼠的存活时间为 (6 .50±2 .41 )d ;仅以环磷酰胺治疗的小鼠存活时间为 (2 0 .90± 2 .88)d ;非转染淋巴细胞和骨髓细胞联合移植组的存活时间为 (1 7.1 0± 4 .65)d ;空载体转染淋巴细胞和骨髓细胞联合移植组的存活时间为(1 7.40± 5 .32 )d ;Ly49A转染淋巴细胞与骨髓细胞联合移植组的存活时间为 (35 .2 0± 1 2 .52 )d ,较上述各组明显延长 (P =0 .0 0 0 )。 Objective To observe the effect of Ly49A transfected lymphocytes on graft versus host disease (GVHD) and graft versus leukemia (GVL) effect post allogeneic bone marrow transplantation. Methods Ly49A gene was transfected into lymphocytes of C57BL/6 mice by retrovirus and the expression rate of Ly49A receptor was detected by flow cytometer. The murine model of allogeneic acute GVHD was established in this way: the donor was C57BL/6(H 2 b). The recipient was BALB/c(H 2 d), which was injected EL9611 cells. After the irradiation (TBI, 60 Co 9.0 Gy) the recipient accepted the transplantation of mixed spleen cells and bone marrow cells to establish the GVHD model. The effects of Ly49A transfected spleen cells on GVHD and GVL post allogeneic bone marrow transplantation were detected. Results The expression rate of Ly49A receptor was ( 42.20 ± 4.87 )?% for lymphocytes transfected with pLXSN Ly49A; ( 18.67 ± 2.48 )?% for lymphocytes transfected with pLXSN and ( 18.73 ± 3.82 )?% for untransfected control respectively. In the case of allo BMT (C57BL/6 H 2 b→BALB/c H 2 d), survival time was ( 6.50 ± 2.41 ) days for the irradiation group; ( 20.90 ± 2.88 ) days for cyclophosphomide therapy group; ( 17.10 ± 4.65 ) days for bone marrow cells mixed with lymphocytes transplantation group; ( 17.40 ± 5.32 ) days for bone marrow cells mixed with pLXSN transfected lymphocytes transplantation group; ( 35.20 ± 12.52 ) days for bone marrow cells mixed with Ly49A transfected lymphocytes transplantation group, which was much longer than the survival time of any of the above group ( P = 0.000 ). Conclusion The Ly49A transfected lymphocytes transplantation could alleviate GVHD and retain GVL effect on acute GVHD model post allo BMT.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2003年第1期11-14,共4页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金资助项目 ( 3 9870 3 3 0 )
关键词 GVL 异基因 骨髓移植 杀伤细胞 移植物抗宿主病 细胞表面受体 GVHD 动物模型 Bone marrow transplantation Killer cells Receptors,cell surface Graft vs host disease
  • 相关文献

参考文献11

  • 1Blazar BR;Murphy WJ.New strategies for preventing graft-versus-host disease,1999.
  • 2Krenger W;Ferrara JLM.Graft-versus-host disease and the Th1/Th2 paradigm[J],1996.
  • 3Takei F;Brennan J;Mager DL.The Ly49 family: genes, proteins and recognition of class I MHC[J],1997.
  • 4李玉华,郭坤元,陈慧,李江琪,王丰,谢匡诚,韦毅,黄建生,任大明.Ly49A 基因转染的淋巴细胞对H—2^d小鼠正常和肿瘤细胞杀伤活性的实验研究[J].中华血液学杂志,2001,22(5):235-237. 被引量:6
  • 5Daniel HF;Kazuhiro K;Rhett S.Donor CD4 enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice,1994.
  • 6Ferrara JLM;Deeg HJ.Graft-versus-host disease,1991.
  • 7Kawano Y;Takaue Y;Watanabe A.Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor,1998(92).
  • 8Tsukada N;Kobata T;Aizawa Y.Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation[J],1999.
  • 9段连宁,郭坤元,刘明,杜江,王三斌,李江琪,李玉华.Th2细胞移植减低异基因骨髓移植后移植物抗宿主病的实验研究[J].中华血液学杂志,2000,21(8):428-429. 被引量:6
  • 10Held W;Raulet DH.Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development[J],1997.

二级参考文献2

  • 1Yan J,J Med Coll PLA,1997年,12卷,132页
  • 2卢圣栋,现代分子生物学实验技术,1993年,393页

共引文献9

同被引文献20

  • 1Pascal V, Stulberg MJ, Anderson SK. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough. Immunol Rev 2006;214(1):9-21
  • 2Kveberg L, Dai KZ, Dissen E. Strain-dependent expression of four structurally related rat Ly49 receptors; correlation with NK gene complex haplotype and NK alloreactivity. Immunogenetics 2006;58(11):905-916
  • 3Bryceson YT, March ME. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006;214(1): 73-91
  • 4Ortaldo JR, Young HA. Mouse Ly49 NK receptors: balancing activation and inhibition. Mol Immunol 2005;42(4):445-450
  • 5Yokoyama WM,Kim S. How do natural killer cells find self to achieve tolerance. Immunity 2006;24(3): 249-257
  • 6Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436(7051):709-713
  • 7Le Maux Chansac B,Moretta A,Vergnon I, et al. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol 2005;175(9):5790-5798
  • 8Natarajan K, Dimasi N, Wang J. MHC class I recognition by Ly49 natural killer cell receptors. Mol Immunol 2002;38(14):1023-1027
  • 9Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295(5562): 2097-2100
  • 10Zamai L, Ponti C, Mirandola P, et al. NK cells and cancer. J Immunol 2007;178(7): 4011-4016

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部